Syncom Formulations (India) Limited (BOM:524470)
India · Delayed Price · Currency is INR 14.24
+0.04 (0.28%)
At close: Feb 12, 2026
BOM:524470 Market Cap
BOM:524470 has a market cap or net worth of 13.39 billion as of February 13, 2026. Its market cap has decreased by -20.13% in one year.
Market Cap
13.39B
Enterprise Value
11.94B
Revenue
5.15B
Ranking
n/a
PE Ratio
22.76
Stock Price
14.24
Market Cap Chart
Since December 31, 2001, BOM:524470's market cap has increased from 267.05M to 13.39B, an increase of 4,912.42%. That is a compound annual growth rate of 17.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 13.39B | -0.21% |
| Dec 31, 2025 | 13.41B | -28.65% |
| Dec 31, 2024 | 18.80B | 32.98% |
| Dec 29, 2023 | 14.14B | 69.37% |
| Dec 30, 2022 | 8.35B | -23.58% |
| Dec 31, 2021 | 10.92B | 305.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novartis India | 20.72B |
| Shukra Pharmaceuticals | 19.52B |
| Amrutanjan Health Care | 18.43B |
| TTK Healthcare | 13.42B |
| Kwality Pharmaceuticals | 12.10B |
| Lincoln Pharmaceuticals | 10.59B |
| Fermenta Biotech | 9.64B |
| Venus Remedies | 9.53B |